Studier FW: Protein production by auto-induction in high density shaking cultures.
Protein Expr Purif 2005,41(1):207–234.
Article
CAS
PubMed
Google Scholar
Ferre H, Ruffet E, Blicher T, Sylvester-Hvid C, Nielsen LL, Hobley TJ, Thomas OR, Buus S: Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: A novel strategy exploiting disulfide assisted protein folding.
Protein Sci 2003,12(3):551–559.
Article
CAS
PubMed
Google Scholar
Hunter WM, Greenwood FC: Preparation of iodine-131 labelled human growth hormone of high specific activity.
Nature 1962, 194:495–496.
Article
CAS
PubMed
Google Scholar
Buus S, Stryhn A, Winther K, Kirkby N, Pedersen LO: Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method.
Biochim Biophys Acta 1995,1243(3):453–460.
PubMed
Google Scholar
Gorga JC, Knudsen PJ, Foran JA, Strominger JL, Burakoff SJ: Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures.
Cell Immunol 1986,103(1):160–173.
Article
CAS
PubMed
Google Scholar
Sidney J, del Guercio MF, Southwood S, Sette A: The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
J Immunol 2002,169(9):5098–5108.
PubMed
Google Scholar
Hitzel C, Gruneberg U, van Ham M, Trowsdale J, Koch N: Sodium dodecyl sulfate-resistant HLA-DR "superdimer" bands are in some cases class II heterodimers bound to antibody.
J Immunol 1999,162(8):4671–4676.
CAS
PubMed
Google Scholar
Arimilli S, Cardoso C, Mukku P, Baichwal V, Nag B: Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
J Biol Chem 1995,270(2):971–977.
Article
CAS
PubMed
Google Scholar
Fischer H, Dohlsten M, Lindvall M, Sjogren HO, Carlsson R: Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
J Immunol 1989,142(9):3151–3157.
CAS
PubMed
Google Scholar
Van Voorhis WC, Steinman RM, Hair LS, Luban J, Witmer MD, Koide S, Cohn ZA: Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages.
J Exp Med 1983,158(1):126–145.
Article
CAS
PubMed
Google Scholar
Charron DJ, McDevitt HO: Analysis of HLA-D region-associated molecules with monoclonal antibody.
Proc Natl Acad Sci USA 1979,76(12):6567–6571.
Article
CAS
PubMed
Google Scholar
Ozato K, Mayer N, Sachs DH: Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.
J Immunol 1980,124(2):533–540.
CAS
PubMed
Google Scholar
Harndahl M, Justesen S, Lamberth K, Roder G, Nielsen M, Buus S: Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.
J Biomol Screen 2009,14(2):173–180.
Article
CAS
PubMed
Google Scholar
Horovitz A, Levitzki A: An accurate method for determination of receptor-ligand and enzyme-inhibitor dissociation constants from displacement curves.
Proc Natl Acad Sci USA 1987,84(19):6654–6658.
Article
CAS
PubMed
Google Scholar
Andersen JT, Justesen S, Berntzen G, Michaelsen TE, Lauvrak V, Fleckenstein B, Buus S, Sandlie I: A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
J Immunol Methods 2008,331(1–2):39–49.
CAS
PubMed
Google Scholar
Ostergaard Pedersen L, Nissen MH, Hansen NJ, Nielsen LL, Lauenmoller SL, Blicher T, Nansen A, Sylvester-Hvid C, Thromsen AR, Buus S: Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds.
Eur J Immunol 2001,31(10):2986–2996.
Article
CAS
PubMed
Google Scholar
Schatz PJ: Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli.
Biotechnology (N Y) 1993,11(10):1138–1143.
CAS
Google Scholar
Leisner C, Loeth N, Lamberth K, Justesen S, Sylvester-Hvid C, Schmidt EG, Claesson M, Buus S, Stryhn A: One-Pot, Mix-and-Read Peptide-MHC Tetramers.
PLoS ONE 2008,3(2):e1678.
Article
PubMed
Google Scholar
Sadegh-Nasseri S, Stern LJ, Wiley DC, Germain RN: MHC class II function preserved by low-affinity peptide interactions preceding stable binding.
Nature 1994,370(6491):647–650.
Article
CAS
PubMed
Google Scholar
Frayser M, Sato AK, Xu L, Stern LJ: Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro.
Protein Expr Purif 1999,15(1):105–114.
Article
CAS
PubMed
Google Scholar
Altman JD, Reay PA, Davis MM: Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli.
Proc Natl Acad Sci USA 1993,90(21):10330–10334.
Article
CAS
PubMed
Google Scholar
Cameron TO, Norris PJ, Patel A, Moulon C, Rosenberg ES, Mellins ED, Wedderburn LR, Stern LJ: Labeling antigen-specific CD4(+) T cells with class II MHC oligomers.
J Immunol Methods 2002,268(1):51–69.
Article
CAS
PubMed
Google Scholar
Park SJ, Sadegh-Nasseri S, Wiley DC: Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1.
Proc Natl Acad Sci USA 1995,92(24):11289–11293.
Article
CAS
PubMed
Google Scholar
Sylvester-Hvid C, Kristensen N, Blicher T, Ferre H, Lauemoller SL, Wolf XA, Lamberth K, Nissen MH, Pedersen LO, Buus S: Establishment of a quantitative ELISA capable of determining peptide – MHC class I interaction.
Tissue Antigens 2002,59(4):251–258.
Article
CAS
PubMed
Google Scholar
Gross U, Schroder AK, Haylett RS, Arlt S, Rink L: The superantigen staphylococcal enterotoxin A (SEA) and monoclonal antibody L243 share a common epitope but differ in their ability to induce apoptosis via MHC-II.
Immunobiology 2006,211(10):807–814.
Article
CAS
PubMed
Google Scholar
Dressel A, Chin JL, Sette A, Gausling R, Hollsberg P, Hafler DA: Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
J Immunol 1997,159(10):4943–4951.
CAS
PubMed
Google Scholar
Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A: Human memory CTL response specific for influenza A virus is broad and multispecific.
Hum Immunol 2000,61(5):438–452.
Article
CAS
PubMed
Google Scholar
Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, Shatney L, Bebris L, Florens L, Dobano C, Witney AA, et al.: Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.
Proc Natl Acad Sci USA 2003,100(17):9952–9957.
Article
CAS
PubMed
Google Scholar
Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A, Snoke K, Serra HM, Kubo RT, Sette A, et al.: Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.
Immunity 1994,1(9):751–761.
Article
CAS
PubMed
Google Scholar
Boritz E, Palmer BE, Livingston B, Sette A, Wilson CC: Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
J Immunol 2003,170(2):1106–1116.
CAS
PubMed
Google Scholar
Sette A, Sidney J, Gaeta FC, Appella E, Colon SM, del Guercio MF, Guery JC, Adorini L: MHC class II molecules bind indiscriminately self and non-self peptide homologs: effect on the immunogenicity of non-self peptides.
Int Immunol 1993,5(6):631–638.
Article
CAS
PubMed
Google Scholar
Bogen B, Lambris JD: Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule.
Embo J 1989,8(7):1947–1952.
CAS
PubMed
Google Scholar
Spouge JL, Guy HR, Cornette JL, Margalit H, Cease K, Berzofsky JA, DeLisi C: Strong conformational propensities enhance T cell antigenicity.
J Immunol 1987,138(1):204–212.
CAS
PubMed
Google Scholar
Livingston BD, Newman M, Crimi C, McKinney D, Chesnut R, Sette A: Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.
Vaccine 2001,19(32):4652–4660.
Article
CAS
PubMed
Google Scholar
Boniface JJ, Reich Z, Lyons DS, Davis MM: Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning.
Proc Natl Acad Sci USA 1999,96(20):11446–11451.
Article
CAS
PubMed
Google Scholar
Carven GJ, Chitta S, Hilgert I, Rushe MM, Baggio RF, Palmer M, Arenas JE, Strominger JL, Horejsi V, Santambrogio L, et al.: Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding.
J Biol Chem 2004,279(16):16561–16570.
Article
CAS
PubMed
Google Scholar
Fontenot AP, Keizer TS, McCleskey M, Mack DG, Meza-Romero R, Huan J, Edwards DM, Chou YK, Vandenbark AA, Scott B, et al.: Recombinant HLA-DP2 Binds Beryllium and Tolerizes Beryllium-Specific Pathogenic CD4+ T Cells.
J Immunol 2006,177(6):3874–3883.
CAS
PubMed
Google Scholar
Chang JW, Mechling DE, Bachinger HP, Burrows GG: Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
J Biol Chem 2001,276(26):24170–24176.
Article
CAS
PubMed
Google Scholar
Cochran JR, Cameron TO, Stern LJ: The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.
Immunity 2000,12(3):241–250.
Article
CAS
PubMed
Google Scholar
Schmitt L, Boniface JJ, Davis MM, McConnell HM: Conformational isomers of a class II MHC-peptide complex in solution.
J Mol Biol 1999,286(1):207–218.
Article
CAS
PubMed
Google Scholar
Stern LJ, Wiley DC: The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.
Cell 1992,68(3):465–477.
Article
CAS
PubMed
Google Scholar
Moro M, Cecconi V, Martinoli C, Dallegno E, Giabbai B, Degano M, Glaichenhaus N, Protti MP, Dellabona P, Casorati G: Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
BMC Immunol 2005, 6:24.
Article
PubMed
Google Scholar
Crawford F, Kozono H, White J, Marrack P, Kappler J: Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.
Immunity 1998,8(6):675–682.
Article
CAS
PubMed
Google Scholar
Thayer WP, Dao CT, Ignatowicz L, Jensen PE: A novel single chain I-A(b) molecule can stimulate and stain antigen-specific T cells.
Mol Immunol 2003,39(14):861–870.
Article
CAS
PubMed
Google Scholar
Karabekian Z, Lytton SD, Silver PB, Sergeev YV, Schneck JP, Caspi RR: Antigen/MHC class II/Ig dimers for study of uveitogenic T cells: IRBP p161–180 presented by both IA and IE molecules.
Invest Ophthalmol Vis Sci 2005,46(10):3769–3776.
Article
PubMed
Google Scholar
Huang JC, Vestberg M, Minguela A, Holmdahl R, Ward ES: Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers.
Int Immunol 2004,16(2):283–293.
Article
CAS
PubMed
Google Scholar
Raki M, Fallang LE, Brottveit M, Bergseng E, Quarsten H, Lundin KE, Sollid LM: Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients.
Proc Natl Acad Sci USA 2007,104(8):2831–2836.
Article
CAS
PubMed
Google Scholar
Xia J, Siegel M, Bergseng E, Sollid LM, Khosla C: Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin.
J Am Chem Soc 2006,128(6):1859–1867.
Article
CAS
PubMed
Google Scholar
Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg O, Lundin KE, Sollid LM: Staining of celiac disease-relevant T cells by peptide-DQ2 multimers.
J Immunol 2001,167(9):4861–4868.
CAS
PubMed
Google Scholar
Gauthier L, Smith KJ, Pyrdol J, Kalandadze A, Strominger JL, Wiley DC, Wucherpfennig KW: Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
Proc Natl Acad Sci USA 1998,95(20):11828–11833.
Article
CAS
PubMed
Google Scholar
Heegaard NH, Hansen BE, Svejgaard A, Fugger LH: Interactions of the human class II major histocompatibility complex protein HLA-DR4 with a peptide ligand demonstrated by affinity capillary electrophoresis.
J Chromatogr A 1997,781(1–2):91–97.
Article
CAS
PubMed
Google Scholar
Hansen BE, Andersson EC, Madsen LS, Engberg J, Sondergaard L, Svejgaard A, Fugger L: Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
Tissue Antigens 1998,51(2):119–128.
Article
CAS
PubMed
Google Scholar
Bioley G, Jandus C, Tuyaerts S, Rimoldi D, Kwok WW, Speiser DE, Tiercy JM, Thielemans K, Cerottini JC, Romero P: Melan-A/MART-1-Specific CD4 T Cells in Melanoma Patients: Identification of New Epitopes and Ex Vivo Visualization of Specific T Cells by MHC Class II Tetramers.
J Immunol 2006,177(10):6769–6779.
CAS
PubMed
Google Scholar
Yang J, James EA, Huston L, Danke NA, Liu AW, Kwok WW: Multiplex mapping of CD4 T cell epitopes using class II tetramers.
Clin Immunol 2006,120(1):21–32.
Article
CAS
PubMed
Google Scholar
Macaubas C, Wahlstrom J, Galvao da Silva AP, Forsthuber TG, Sonderstrup G, Kwok WW, DeKruyff RH, Umetsu DT: Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals.
J Immunol 2006,176(8):5069–5077.
CAS
PubMed
Google Scholar
Hugues S, Malherbe L, Filippi C, Glaichenhaus N: Generation and use of alternative multimers of peptide/MHC complexes.
J Immunol Methods 2002,268(1):83–92.
Article
CAS
PubMed
Google Scholar
Appel H, Gauthier L, Pyrdol J, Wucherpfennig KW: Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
J Biol Chem 2000,275(1):312–321.
Article
CAS
PubMed
Google Scholar
Arnold PY, La Gruta NL, Miller T, Vignali KM, Adams PS, Woodland DL, Vignali DA: The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.
J Immunol 2002,169(2):739–749.
CAS
PubMed
Google Scholar
Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, Svejgaard A, Bell JI, Strominger JL, Jones EY, Fugger L: Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.
Proc Natl Acad Sci USA 2004,101(7):1999–2004.
Article
CAS
PubMed
Google Scholar
Anderson MW, Gorski J: Cooperativity during the formation of peptide/MHC class II complexes.
Biochemistry 2005,44(15):5617–5624.
Article
CAS
PubMed
Google Scholar
Scheirle A, Takacs B, Kremer L, Marin F, Sinigaglia F: Peptide binding to soluble HLA-DR4 molecules produced by insect cells.
J Immunol 1992,149(6):1994–1999.
CAS
PubMed
Google Scholar
Fourneau JM, Cohen H, van Endert PM: A chaperone-assisted high yield system for the production of HLA-DR4 tetramers in insect cells.
J Immunol Methods 2004,285(2):253–264.
Article
CAS
PubMed
Google Scholar
Kalandadze A, Galleno M, Foncerrada L, Strominger JL, Wucherpfennig KW: Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
J Biol Chem 1996,271(33):20156–20162.
Article
CAS
PubMed
Google Scholar
Boder ET, Bill JR, Nields AW, Marrack PC, Kappler JW: Yeast surface display of a noncovalent MHC class II heterodimer complexed with antigenic peptide.
Biotechnol Bioeng 2005,92(4):485–491.
Article
CAS
PubMed
Google Scholar
Esteban O, Zhao H: Directed evolution of soluble single-chain human class II MHC molecules.
J Mol Biol 2004,340(1):81–95.
Article
CAS
PubMed
Google Scholar
Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, Sant AJ: The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
Immunity 2005,23(1):29–40.
Article
CAS
PubMed
Google Scholar
Denzin LK, Hammond C, Cresswell P: HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.
J Exp Med 1996,184(6):2153–2165.
Article
CAS
PubMed
Google Scholar
De Wall SL, Painter C, Stone JD, Bandaranayake R, Wiley DC, Mitchison TJ, Stern LJ, DeDecker BS: Noble metals strip peptides from class II MHC proteins.
Nat Chem Biol 2006,2(4):197–201.
Article
CAS
PubMed
Google Scholar
Rabinowitz JD, Vrljic M, Kasson PM, Liang MN, Busch R, Boniface JJ, Davis MM, McConnell HM: Formation of a highly peptide-receptive state of class II MHC.
Immunity 1998,9(5):699–709.
Article
CAS
PubMed
Google Scholar
Yang J, Jaramillo A, Shi R, Kwok WW, Mohanakumar T: In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.
Hum Immunol 2004,65(7):692–699.
Article
CAS
PubMed
Google Scholar
Novak EJ, Liu AW, Nepom GT, Kwok WW: MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.
J Clin Invest 1999,104(12):R63–67.
Article
CAS
PubMed
Google Scholar
Reichstetter S, Ettinger RA, Liu AW, Gebe JA, Nepom GT, Kwok WW: Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response.
J Immunol 2000,165(12):6994–6998.
CAS
PubMed
Google Scholar
Kwok WW, Liu AW, Novak EJ, Gebe JA, Ettinger RA, Nepom GT, Reymond SN, Koelle DM: HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells.
J Immunol 2000,164(8):4244–4249.
CAS
PubMed
Google Scholar
Yang J, Huston L, Berger D, Danke NA, Liu AW, Disis ML, Kwok WW: Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells.
J Clin Immunol 2005,25(5):428–436.
Article
CAS
PubMed
Google Scholar
Hamad AR, O'Herrin SM, Lebowitz MS, Srikrishnan A, Bieler J, Schneck J, Pardoll D: Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor.
J Exp Med 1998,188(9):1633–1640.
Article
CAS
PubMed
Google Scholar
Masteller EL, Warner MR, Ferlin W, Judkowski V, Wilson D, Glaichenhaus N, Bluestone JA: Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
J Immunol 2003,171(10):5587–5595.
CAS
PubMed
Google Scholar
Buus S, Sette A, Colon SM, Grey HM: Autologous peptides constitutively occupy the antigen binding site on Ia.
Science 1988,242(4881):1045–1047.
Article
CAS
PubMed
Google Scholar
Burrows GG, Chang JW, Bachinger HP, Bourdette DN, Offner H, Vandenbark AA: Design, engineering and production of functional single-chain T cell receptor ligands.
Protein Eng 1999,12(9):771–778.
Article
CAS
PubMed
Google Scholar
Castelli FA, Buhot C, Sanson A, Zarour H, Pouvelle-Moratille S, Nonn C, Gahery-Segard H, Guillet JG, Menez A, Georges B, et al.: HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.
J Immunol 2002,169(12):6928–6934.
CAS
PubMed
Google Scholar
Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW: Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles.
J Immunol 2006,176(3):1988–1998.
CAS
PubMed
Google Scholar
Berretta F, Butler RH, Diaz G, Sanarico N, Arroyo J, Fraziano M, Aichinger G, Wucherpfennig KW, Colizzi V, Saltini C, et al.: Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity.
Tissue Antigens 2003,62(6):459–471.
Article
CAS
PubMed
Google Scholar
Fridkis-Hareli M, Rosloniec EF, Fugger L, Strominger JL: Synthetic peptides that inhibit binding of the collagen type II 261–273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses.
Hum Immunol 2000,61(7):640–650.
Article
CAS
PubMed
Google Scholar
Rotzschke O, Lau JM, Hofstatter M, Falk K, Strominger JL: A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules.
Proc Natl Acad Sci USA 2002,99(26):16946–16950.
Article
CAS
PubMed
Google Scholar
Wilkinson RJ, Wilkinson KA, Jurcevic S, Hills A, Sinha S, Sengupta U, Lockwood DN, Katoch K, Altman D, Ivanyi J: Specificity and function of immunogenic peptides from the 35-kilodalton protein of Mycobacterium leprae.
Infect Immun 1999,67(3):1501–1504.
CAS
PubMed
Google Scholar
Jurcevic S, Hills A, Pasvol G, Davidson RN, Ivanyi J, Wilkinson RJ: T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles.
Clin Exp Immunol 1996,105(3):416–421.
Article
CAS
PubMed
Google Scholar
Caccamo N, Meraviglia S, La Mendola C, Bosze S, Hudecz F, Ivanyi J, Dieli F, Salerno A: Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis.
Eur J Immunol 2004,34(8):2220–2229.
Article
CAS
PubMed
Google Scholar
Mertz AK, Wu P, Sturniolo T, Stoll D, Rudwaleit M, Lauster R, Braun J, Sieper J: Multispecific CD4+ T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles.
J Immunol 2000,164(3):1529–1537.
CAS
PubMed
Google Scholar
Vollers SS, Stern LJ: Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.
Immunology 2008,123(3):305–313.
Article
CAS
PubMed
Google Scholar
Kang JH, Maeng CY, Park JH, Hahm KS, Han BD, Kim KL: Reassembly and reconstitution of separate alpha and beta chains of human leukocyte antigen DR4 molecule isolated from Escherichia coli.
Mol Cells 1997,7(2):237–243.
CAS
PubMed
Google Scholar